✦ LIBER ✦

Prognostic studies in patients with high-risk primary breast cancer (HRPBC) receiving high-dose chemotherapy (HDC)

✍ Scribed by Y Nieto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term Analysis and Prospective Valid

✍ Snyder-Dougherty, L.; Goldstein, L.J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 64 KB

30 Prognostic analysis of the early lymp

✍ Y. Nieto; R.B. Jones; S.I. Bearman; I.K. McNiece; P.A. McSweeney; E.J. Shpall 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Randomized studies of high-dose chemothe

✍ S. Rodenhuis; E.G.E. De Vries 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 161 KB

28 Long-term analysis of high-risk prima

✍ Y. Nieto; E.J. Shpall; S.I. Bearman; P.A. McSweeney; R.B. Jones 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Protein Expression Profiling in High-Ris

✍ Carey, L.A. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

High-dose chemotherapy for high-risk pri

✍ Raymond B Weiss; Robert M Rifkin; F Marc Stewart; Richard L Theriault; Lori A Wi 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 85 KB